Login Preferences
About News Publications Statistics Downloads API Guide License How to use Preferences
bn:00356943n
Noun Concept
Categories: Breakthrough therapy, Antineoplastic drugs, Novartis brands, Monoclonal antibodies
EN
canakinumab  ACZ-885  ACZ885  ATC code L04AC08  ATCvet code QL04AC08
EN
Canakinumab, sold under the brand name Ilaris, is a medication for the treatment of systemic juvenile idiopathic arthritis, active Still's disease, including adult-onset Still's disease, gout flares. Wikipedia
Definitions
Relations
Sources
EN
Canakinumab, sold under the brand name Ilaris, is a medication for the treatment of systemic juvenile idiopathic arthritis, active Still's disease, including adult-onset Still's disease, gout flares. Wikipedia
Pharmaceutical drug Wikidata
IS A
compound
medicine
monoclonal antibody
biopharmaceutical
Wikipedia
EN
canakinumab
Wikidata
EN
Canakinumab
Wikipedia Redirections
EN
ACZ885, ATC code L04AC08, ATCvet code QL04AC08, C6452H9958N1722O2010S42, Ilaris
Wikidata Alias
EN
ACZ-885, ACZ885, Ilaris

Please note that, in order to improve your browsing experience on this website, BabelNet® uses various types of cookies, including: browsing functionality, performance and statistical cookies.

By continuing to browse the site you are agreeing to our use of cookies. OK

License